000			03469cam a2200373Ii 4500
001			95180
003			ES-MaUEC
005			20230102112651.0
006			m o d
007			cr cnu|||unuuu
008			170109s2017 si a o 000 0 eng d
020			_a9789812878397
020			_a9789812878403 _q(electronic bk.)
020			_a9812878394
020			_a9812878408 _q(electronic bk.)
020			_z9789812878397 _q(print)
035			_a(OCoLC)967938189 _z(OCoLC)968317808 _z(OCoLC)974651117 _z(OCoLC)981106064 _z(OCoLC)981777307 _z(OCoLC)1005781222 _z(OCoLC)1011847482
040			_aN$T _cN$T _dIDEBK _dGW5XE _dN$T _dEBLCP _dUAB _dNJR _dYDX _dCOO _dUPM _dOCLCO _dOCLCF _dOCLCO _dVT2 _dIOG _dESU _dZ5A _dJBG _dIAD _dICW _dICN _dOTZ _dOCLCQ _dOCLCO _dU3W _dES-MaUEC _bspa
050		4	_aRC776.P87 _b2017 EB
245	0	0	_aDiagnosis and treatment of pulmonary hypertension : _bfrom bench to bedside _cYoshihiro Fukumoto, editor.
264		1	_aSingapore _bSpringer International Publishing _c2017
300			_a1 recurso en línea (viii, 236 páginas) _bilustraciones (algunas a color)
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF _2rda
505	0		_aPart I Fundamentals of Pulmonary Hypertension -- 1. Clinical Classification -- 2. Diagnosis? Imagings -- Part II Pathophysiology and Genetics -- 3. Pathogenic and Therapeutic Role of MicroRNA in Pulmonary Arterial Hypertension -- 4. Sex Hormones -- 5. Rho-Kinase -- 6. The Unique Property of the Pulmonary Artery Regard-ing the Smooth Muscle Effects of Proteinase-activated Receptor 1 -- The Possible Contribution to the Pathogenesis of Pulmonary Hypertension -- 7. Animal Models with Pulmonary Hypertension -- 8. Human Pathology -- 9. Pathophysiology and Genetics: BMPR2 -- Part III Treatment of Pulmonary Arterial Hypertension (PAH) -- 10. Prostacyclin -- 11. Targeting the NO-sGC-cGMP pathway in pulmonary arterial hypertension -- 12. Endothelin Receptor Antagonist -- 13. LUNG TRANSPLANTATION -- Part IV Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) -- 14. Medical Therapy for Chronic Thromboembolic Pulmonary Hypertension -- 15. Balloon Pulmonary Angioplasty -- 16. Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension -- Part V Right Ventricular Function -- 17. Right Ventricular Function.
520	3		_aThis book focuses on pulmonary arterial hypertension (PAH, Group 1) and chronic thromboembolic pulmonary hypertension (CTEPH, Group 4) among the various groups of pulmonary hypertension (PH) whose classification was updated into five major categories at the 5th World Symposium held in Nice, France, in 2013. Readers will find recent progress, methods, and up-to-date information on PH mechanisms, diagnostic images, and treatment in the management of PH. This volume, with contributions by leading researchers worldwide in the field, consists of five parts, starting with the fundamentals of PH, then pathophysiology and genetics, treatment, and right ventricular function.
650		7	_9138557 _aCardiología _2fast _0(OCoLC)fst00847121 _0
700	1		_aFukumoto, Yoshihiro, _eeditor literario
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-981-287-840-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988			_aSpringer_Medicine_2017
998			_b02/2018 _dz _e- _zSI
999			_c95180 _d95180 _x1